Tecar Therapy in Chronic Knee Osteoarthritis

ConditionOsteearthritis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40-75

SponsorKirsehir Ahi Evran Universitesi

About this trial

This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.

Eligibility criteria

Qualifiers

Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis

Patients with bilateral knee pain for at least 6 weeks

Male and female patients aged 40-75

Patients who accept and sign the informed consent form

Disqualifiers

Those who have received physical therapy for knee pain in the last 6 months

Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months

Those who have undergone knee surgery for any reason

Those with inflammatory arthritis

Trial design

Treatments tested in this trial

Tecar Therapy
ShamTecar Therapy
conventional physical therapy

Treatment groups

60 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Kirsehir Ahi Evran Universitesi

Lead sponsor

Source ClinicalTrials.gov